Crossmark

Long-Term Efficacy of Vismodegib After its Withdrawal and Patients’ Health-Related Quality of Life Using the Dermatology Life Quality Index (DLQI)

Crossref DOI link: https://doi.org/10.1007/s13555-019-00323-4

Published Online: 2019-09-10

Published Print: 2019-12

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Villani, Alessia

Megna, Matteo

Fabbrocini, Gabriella

Cappello, Milena

Luciano, Maria Antonietta

Costa, Claudia

Scalvenzi, Massimiliano
More Information

Article History

Received: 26 July 2019

First Online: 10 September 2019